FDA Import Refusal 1FX-3890120-3/10002/2 — CI FARMACAPSULAS SAS
The FDA refused shipment 1FX-3890120-3/10002/2 from CI FARMACAPSULAS SAS (Colombia) on July 7, 2026. The refused product falls under Drugs and Biologics — SERTRALINE HYDROCHLORIDE (ANTI-DEPRESSANT). Cited charges: 118,75
Refusal Details
- Date
- July 7, 2026
- Country
- Colombia
- Product Category
- Drugs and Biologics
- Product Code
- 61NCY78 SERTRALINE HYDROCHLORIDE (ANTI-DEPRESSANT)
- Charges
- 118,75